David Michael Johnson, Director at Aura Biosciences, Inc. (AURA), bought 20,000 shares at $4.90 ($98K) on 2025-05-16, disclosed to the SEC on 2025-05-20.
Open-market purchase of $98k AURA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| AURA | BUY | 2023-10-05 | $225K | — | Filing → |
| AURA | BUY | 2023-01-09 | $21K | — | Filing → |
| AURA | BUY | 2022-12-30 | $20K | — | Filing → |